Cargando…

Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer

BACKGROUND: Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant. Limited knowledge is available on the challenges met when conducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorsen, Lene, Kirkegaard, Camilla, Loge, Jon Håvard, Kiserud, Cecilie E., Johansen, Merethe Lia, Gjerset, Gunhild M., Edvardsen, Elisabeth, Hamre, Hanne, Ikdahl, Tone, Fosså, Sophie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472911/
https://www.ncbi.nlm.nih.gov/pubmed/28619116
http://dx.doi.org/10.1186/s13104-017-2531-y
_version_ 1783244204658393088
author Thorsen, Lene
Kirkegaard, Camilla
Loge, Jon Håvard
Kiserud, Cecilie E.
Johansen, Merethe Lia
Gjerset, Gunhild M.
Edvardsen, Elisabeth
Hamre, Hanne
Ikdahl, Tone
Fosså, Sophie D.
author_facet Thorsen, Lene
Kirkegaard, Camilla
Loge, Jon Håvard
Kiserud, Cecilie E.
Johansen, Merethe Lia
Gjerset, Gunhild M.
Edvardsen, Elisabeth
Hamre, Hanne
Ikdahl, Tone
Fosså, Sophie D.
author_sort Thorsen, Lene
collection PubMed
description BACKGROUND: Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant. Limited knowledge is available on the challenges met when conducting PA intervention trials in patients with TC during and shortly after chemotherapy. The aims of the present feasibility study are therefore to determine patient recruitment, compliance and adherence to a PA intervention. RESULTS: Patients with metastatic TC referred to cisplatin-based chemotherapy were eligible. They followed an individual low-threshold PA intervention, including counseling from a personal coach during and 3 months after chemotherapy. Outcomes were recruitment rate, compliance rate and adherence to the intervention including preferences for type of PA and barriers for PA. During 8 months 12 of 18 eligible patients were invited, all consented, but three dropped out. Walking and low intensity activities were preferred and nausea and feeling unwell were the most often reported barriers towards PA. DISCUSSION: In order to achieve adequate recruitment, compliance and complete data in future PA intervention trials, close cooperation with treating physicians, individual PA plans and availability of personalized coaching are required. Trial registration NCT01749774, November 2012, ClinicalTrials.gov ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-017-2531-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5472911
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54729112017-06-21 Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer Thorsen, Lene Kirkegaard, Camilla Loge, Jon Håvard Kiserud, Cecilie E. Johansen, Merethe Lia Gjerset, Gunhild M. Edvardsen, Elisabeth Hamre, Hanne Ikdahl, Tone Fosså, Sophie D. BMC Res Notes Project Note BACKGROUND: Given the risk of developing acute and long-term adverse effects in patients receiving cisplatin-based chemotherapy for testicular cancer (TC), risk-reducing interventions, such as physical activity (PA), may be relevant. Limited knowledge is available on the challenges met when conducting PA intervention trials in patients with TC during and shortly after chemotherapy. The aims of the present feasibility study are therefore to determine patient recruitment, compliance and adherence to a PA intervention. RESULTS: Patients with metastatic TC referred to cisplatin-based chemotherapy were eligible. They followed an individual low-threshold PA intervention, including counseling from a personal coach during and 3 months after chemotherapy. Outcomes were recruitment rate, compliance rate and adherence to the intervention including preferences for type of PA and barriers for PA. During 8 months 12 of 18 eligible patients were invited, all consented, but three dropped out. Walking and low intensity activities were preferred and nausea and feeling unwell were the most often reported barriers towards PA. DISCUSSION: In order to achieve adequate recruitment, compliance and complete data in future PA intervention trials, close cooperation with treating physicians, individual PA plans and availability of personalized coaching are required. Trial registration NCT01749774, November 2012, ClinicalTrials.gov ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-017-2531-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-15 /pmc/articles/PMC5472911/ /pubmed/28619116 http://dx.doi.org/10.1186/s13104-017-2531-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Project Note
Thorsen, Lene
Kirkegaard, Camilla
Loge, Jon Håvard
Kiserud, Cecilie E.
Johansen, Merethe Lia
Gjerset, Gunhild M.
Edvardsen, Elisabeth
Hamre, Hanne
Ikdahl, Tone
Fosså, Sophie D.
Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title_full Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title_fullStr Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title_full_unstemmed Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title_short Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
title_sort feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
topic Project Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472911/
https://www.ncbi.nlm.nih.gov/pubmed/28619116
http://dx.doi.org/10.1186/s13104-017-2531-y
work_keys_str_mv AT thorsenlene feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT kirkegaardcamilla feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT logejonhavard feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT kiserudceciliee feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT johansenmerethelia feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT gjersetgunhildm feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT edvardsenelisabeth feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT hamrehanne feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT ikdahltone feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer
AT fossasophied feasibilityofaphysicalactivityinterventionduringandshortlyafterchemotherapyfortesticularcancer